glp-1 agonist drugs list GLP-1 nausea: How to handle GLP-1s' most common side effect list of glp 1 medications

34 The trial had a total of 731 patients with a baseline mean A1C of 8.2% and a baseline total daily dose of insulin ranging from 56 to 62 units, depending on the treatment group

J Clin Endocrinol Metab 103(1):288294

DPP4-Inhibitor Improves Neuronal Insulin Receptor Function, Brain Mitochondrial Function and Cognitive Function in Rats With Insulin Resistance Induced by High-Fat Diet Consumption

weight loss at target dose (trial data) ~21% (SURMOUNT) CV risk reduction labelled Under study Format Prefilled KwikPen + single-dose autoinjector India price (May 2026) 14,00027,500/month DCGI-approved Yes (March 2025) Generic competition in India No no Indian biosimilar yet Weight-loss percentages are trial averages at target dose individual response varies

GLP-1RAs are known to delay gastric emptying a condition in which the stomach empties slower than normal potentially leading to the presence of residual gastric content (RGC) in appropriately fasted patients

However, meta-analyses incorporating larger cohort studies have demonstrated no significant correlation with elevated pancreatic cancer risk, although the relatively brief duration of these cohort studies may influence these conclusions [25]